Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612672 · ClinicalTrials.gov registry record · NA
Evaluation of GeoHAI Implementation
A NA study of Clostridioides Difficile Infection and Healthcare Associated Infection, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05612672: Recruiting NA study of Clostridioides Difficile Infection and Healthcare Associated Infection, sponsored by Ohio State University.
NCT05612672 is a NA study of Clostridioides Difficile Infection and Healthcare Associated Infection that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 25 participants, below the 421-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612672, a NA study of Clostridioides Difficile Infection and Healthcare Associated Infection, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and evaluating a new computer application which incorporates mapping and geographic data to assist hospital epidemiologists in identifying HAI clusters and assessing transmission risk. We expect that incorporation of geographic information into the workflow of hospital epidemiologists will have a profound effect on our understanding of disease transmission and HAI risk factors in the hospital setting, radically altering the workflow and speed of response of infection preventionists and improving their ability to prevent HAIs.
Primary Outcome
HAI rate at healthcare system level before intervention and after
Conditions Studied
Interventions
- OTHER GeoHAI
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What NCT05612672 shows while recruiting
NCT05612672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 421-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Clostridioides Difficile Infection appearing as the primary indexed condition, and to 1 intervention - of which GeoHAI is the first listed.
NCT05612672 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05612672 about?
NCT05612672 is a clinical study titled "Evaluation of GeoHAI Implementation". Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and e...
What is the current status of trial NCT05612672?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-13. Estimated completion is 2025-09-30.
What conditions does trial NCT05612672 study?
This clinical trial studies the following conditions: Clostridioides Difficile Infection, Healthcare Associated Infection.
What interventions are being tested in trial NCT05612672?
The interventions under investigation include: GeoHAI (OTHER).
Who is sponsoring clinical trial NCT05612672?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05612672 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridioides Difficile Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
RECRUITING · Phase 2
-
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
RECRUITING · Phase 2
-
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
RECRUITING · Phase 3
-
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
RECRUITING · Phase 2
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
COMPLETED
-
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI